Literature DB >> 6444585

Chemotherapy for bladder cancer with neocarzinostatin: evaluation of systemic administration.

S Sakamoto, J Ogata, K Ikegami, H Maeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6444585     DOI： 10.1016/0014-2964(80)90115-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.

Authors:  E Otsuji; T Takahashi; T Yamaguchi; N Yamaguchi; J Imanishi
Journal:  Gastroenterol Jpn       Date:  1990-04

2.  "Two-route chemotherapy" using high-dose intra-arterial neocarzinostatin and systemic tiopronin, its antidote, for rat limb tumor.

Authors:  Y Iwamoto; T Kuroiwa; K Aoki; T Baba
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.

Authors:  T Oda; H Yamamoto; T Miki; H Maeda
Journal:  Jpn J Cancer Res       Date:  1989-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.